製薬における人工知能(AI)の世界市場2021年-2031年

visiongainが発行した調査報告書(VGA21MA027)
◆英語タイトル:Artificial Intelligence (AI) in Pharmaceutical Market Report 2021-2031
◆商品コード:VGA21MA027
◆発行会社(リサーチ会社):visiongain
◆発行日:2021年2月
◆ページ数:353
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:IT
◆販売価格オプション(消費税別)
Sigle User(1名様閲覧用、1年間、印刷不可)USD4,549 ⇒換算¥500,390見積依頼/購入/質問フォーム
Global Site License(法人閲覧用、1年間、印刷可)USD9,099 ⇒換算¥1,000,890見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、世界の製薬における人工知能(AI)の市場について調査・分析し、レポート概要、エグゼクティブサマリー、市場動向、用途別(創薬、精密医療、医用画像・診断、研究)分析、技術別(機械学習、その他)分析、提供別(ハードウェア、ソフトウェア、サービス)分析、展開別(クラウド型、オンプレミス型)分析、地域別分析、企業情報などの項目を掲載しています。
・レポート概要
・エグゼクティブサマリー
・市場動向
・世界の製薬における人工知能(AI)市場規模:用途別(創薬、精密医療、医用画像・診断、研究)
・世界の製薬における人工知能(AI)市場規模:技術別(機械学習、その他)
・世界の製薬における人工知能(AI)市場規模:提供別(ハードウェア、ソフトウェア、サービス)
・世界の製薬における人工知能(AI)市場規模:展開別(クラウド型、オンプレミス型)
・世界の製薬における人工知能(AI)市場規模:地域別
・企業情報
【レポートの概要】

How Adoption of Artificial Intelligence Impacting Pharmaceutical Industry?

The global pharmaceuticals industry is in the throes of transition, both clinical trials and regulatory approvals have been challenged by the proliferation of specialized drugs catering to smaller patient groups. In order to boost results in drug discovery, clinical trials, and research and development, the pharmaceutical and life sciences companies are switching to robotic process control, artificial intelligence and machine learning. All these factors are anticipated to propel demand for artificial intelligence in pharmaceutical across the globe.

Artificial Intelligence Anticipated to Revolutionize Several Aspects of Pharmaceutical Industry

The way drugs are made, prescribed and ingested today will be standardized by artificial intelligence. Many facets of the pharmaceuticals and life sciences industry will also be revolutionized but will not heal sickness or replace physicians. Understanding the main aim of artificial intelligence, which is to improve human capability and accomplishment instead of challenging it, would dispel much of the technology’s concerns and put out its excellent ability to serve humanity.

Which Factors are Fueling AI in Pharmaceuticals Industry Growth?
• Growing Complexity of Modern Pharmacology
• Growing Demand for Viable Therapeutic Candidates
• Improves Overall R&D Productivity
• Concerns Associated with Rising Capital Requirements in Drug Discovery
• Increasing Awareness Related to Artificial Intelligence Among Pharmaceutical Manufacturers
Which Factors are Restraining Growth?
• Lack of Skilled Professionals
• Limited Availability of Datasets
UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

How do prominent players strengthen their position throughout the world?

You must read this newly updated report if you are involved in this sector. The report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks.

Discover how to stay ahead

Our 350+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing AI in Pharmaceuticals Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, PEST Analysis, Porter’s Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and submarkets

Application
• Drug Discovery
• Precision Medicine
• Medical Imaging & Diagnostics
• Research
Technology
• Machine Learning
• Other Technologies
Offering
• Hardware
• Software
• Services
Deployment
• Cloud
• On-Premises
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 13 leading national markets:

By Region (Segmental Breakdown for All the Regions)
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• RoW

【レポートの目次】

1. Report Overview
1.1 Introduction to Artificial Intelligence in Pharmaceutical Market
1.2 Artificial Intelligence in Pharmaceutical Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Growing Complexity of Modern Pharmacology
3.1.2 Growing Demand for Viable Therapeutic Candidates
3.1.3 Improves Overall R&D Productivity
3.2 Restraints
3.2.1 Lack of Skilled Professionals
3.2.2 Limited Availability of Datasets
3.3 Opportunities
3.3.1 Adoption of AI in Drug Discovery
3.3.2 Rise of AI Across Biopharma
3.3.3 Cost Efficiency
3.3.4 Artificial Intelligence for Genomic Medicine
3.4 AI in Pharmaceuticals: Trends
3.4.1 Identifying Patients for Clinical Trials
3.4.2 Identifying Chemical Compounds
3.4.3 Machine Learning & Supply Chain
3.4.4 Machine Learning & Prescription Optimization
3.4.5 Data Science in Pharmaceutical Industry
3.5 SWOT Analysis
3.5.1 Strengths
3.5.2 Weaknesses
3.5.3 Opportunities
3.5.4 Threats
3.6 Industry analysis – Porter’s
3.6.1 Buyer Power
3.6.2 Supplier Power
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitute
3.6.5 Threat of New Entrants
3.7 Industry analysis – PEST Analysis
3.7.1 Political Factors Impacting AI in Pharmaceuticals
3.7.2 Economical
3.7.3 Social
3.7.4 Technological
4 Artificial Intelligence in Pharmaceutical Market by Application
4.1 Drug Discovery Segment Market Forecast, 2021-2031
4.1.1 Drug Discovery Segment Accounts for Majority of the Market Share
4.1.2 AI in Drug Screening to Fuel Market Growth
4.1.3 Recovery Scenarios (V, U, W, L)
4.2 Precision Medicine Segment Market Forecast, 2021-2031
4.2.1 Precision Medicine Segment to Witness Fastest Growth Rate Through 2031
4.2.2 Recovery Scenarios (V, U, W, L)
4.3 Medical Imaging & Diagnostics Segment Market Forecast, 2021-2031
4.3.1 Adoption of AI in Medical Imaging to Diagnose Wide Variety of Conditioons
4.3.2 Recovery Scenarios (V, U, W, L)
4.4 Research Segment Market Forecast, 2021-2031
4.4.1 Increasing Cost and Timelines for Drug Development to Fuel Adoption of AI in Research
4.4.2 Recovery Scenarios (V, U, W, L)
5 Artificial Intelligence in Pharmaceutical Market by Technology
5.1 Machine Learning Segment Market Forecast, 2021-2031
5.1.1 Burgeoning Applications of ML in Pharma are Glimmers of a Potential Future
5.1.2 Recovery Scenarios (V, U, W, L)
5.2 Other Technologies Segment Market Forecast, 2021-2031
5.2.1 Recovery Scenarios (V, U, W, L)
6 Artificial Intelligence in Pharmaceutical Market by Offering
6.1 Hardware Segment Market Forecast, 2021-2031
6.1.1 Recovery Scenarios (V, U, W, L)
6.2 Software Segment Market Forecast, 2021-2031
6.2.1 Recovery Scenarios (V, U, W, L)
6.3 Services Segment Market Forecast, 2021-2031
6.3.1 Recovery Scenarios (V, U, W, L)
7 Artificial Intelligence in Pharmaceutical Market by Deployment
7.1 Cloud Segment Market Forecast, 2021-2031
7.1.1 Cloud Segment Accounts for Majority of the Market Share
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 On-Premise Segment Market Forecast, 2021-2031
7.2.1 Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Artificial Intelligence in Pharmaceutical Market Forecasts 2021-2031
8.1 Global Artificial Intelligence in Pharmaceutical Market by Region Forecast 2021-2031
8.2 Recovery Scenarios (V, U, W, L)
9 North America Artificial Intelligence in Pharmaceutical Market
9.1 North America Artificial Intelligence in Pharmaceutical Market by Country, Forecast 2021-2031
9.2 North America Artificial Intelligence in Pharmaceutical Market Forecast by Application
9.2.1 Recovery Scenarios (V, U, W, L): North America Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031
9.3 North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology
9.3.1 Recovery Scenarios (V, U, W, L): North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031
9.4 North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering
9.4.1 Recovery Scenarios (V, U, W, L): North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031
9.5 North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment
9.5.1 Recovery Scenarios (V, U, W, L): North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031
9.6 U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
9.6.1 U.S. Accounts for Majority of the Global AI in Pharmaceutical Market Share
9.6.2 Recovery Scenarios (V, U, W, L): U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
9.7 Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
9.7.1 Canadian AI in Pharma to Witness Fastest Growth Rate Across North American Region
9.7.2 Recovery Scenarios (V, U, W, L): Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10 Europe Artificial Intelligence in Pharmaceutical Market
10.1 Europe Artificial Intelligence in Pharmaceutical Market by Country, Forecast 2021-2031
10.2 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application
10.2.1 Recovery Scenarios (V, U, W, L): Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031
10.3 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology
10.3.1 Recovery Scenarios (V, U, W, L): Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031
10.4 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering
10.4.1 Recovery Scenarios (V, U, W, L): Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031
10.5 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment
10.5.1 Recovery Scenarios (V, U, W, L): Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031
10.6 UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.6.1 Collaboration Between Multinational Pharma and AI Driven Drug Discovery Companies to Fuel Regional Growth
10.6.2 Recovery Scenarios (V, U, W, L): UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.7 Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.7.1 Germany Dominates the European AI in Pharmaceutical Market
10.7.2 Recovery Scenarios (V, U, W, L): Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.8 France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.8.1 French AI in Pharma to Offer Lucrative Growth Opportunities
10.8.2 Recovery Scenarios (V, U, W, L): France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.9 Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.9.1 Growing R&D Funding to Boost Italian AI in Pharmaceutical Market
10.9.2 Recovery Scenarios (V, U, W, L): Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.10 Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.10.1 Recovery Scenarios (V, U, W, L): Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.11 Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.11.1 Recovery Scenarios (V, U, W, L): Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11 Asia Pacific Artificial Intelligence in Pharmaceutical Market
11.1 Asia Pacific AI in Pharmaceutical to Witness Fastest CAGR Between 2021 to 2031
11.2 Asia Pacific Artificial Intelligence in Pharmaceutical Market by Country, Forecast 2021-2031
11.3 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application
11.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031
11.4 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology
11.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031
11.5 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering
11.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031
11.6 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment
11.6.1 Recovery Scenarios (V, U, W, L): Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031
11.7 Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.7.1 Japan AI in Pharma Accounts for Majority of the APAC Market
11.7.2 Recovery Scenarios (V, U, W, L): Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.8 China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.8.1 Big Data and Artificial Intelligence to Have Significant Impact on Chinese Pharmaceutical Sector
11.8.2 Recovery Scenarios (V, U, W, L): China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.9 India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.9.1 Indian AI in Pharmaceutical to Witness Fastest CAGR Over the Forecast Period
11.9.2 Recovery Scenarios (V, U, W, L): India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.10 Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.10.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
12 RoW Artificial Intelligence in Pharmaceutical Market
12.1 RoW Artificial Intelligence in Pharmaceutical Market, Forecast 2021-2031
12.1.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
12.2 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application
12.2.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031
12.3 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology
12.3.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031
12.4 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering
12.4.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031
12.5 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment
12.5.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031
13 Company Profiles
13.1 Microsoft Corporation
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2015-2019
13.1.3.2 R&D Expenses, 2015-2019
13.1.3.3 Gross Profit, 2015-2019
13.1.3.4 Net Income, 2015-2019
13.1.3.5 EBDITA, 2015-2019
13.1.4 Product Benchmarking
13.1.5 Recent Developments, 2017-2020
13.2 NVIDIA Corporation
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2015-2019
13.2.3.2 R&D Expenses, 2015-2019
13.2.3.3 Gross Profit, 2015-2019
13.2.3.4 Net Income, 2015-2019
13.2.3.5 EBDITA, 2015-2019
13.2.4 Product Benchmarking
13.2.5 Recent Developments, 2017-2020
13.3 IBM Corporation
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2015-2019
13.3.3.2 R&D Expenses, 2015-2019
13.3.3.3 Gross Profit, 2015-2019
13.3.3.4 Net Income, 2015-2019
13.3.3.5 EBDITA, 2015-2019
13.3.4 Product Benchmarking
13.4 Alphabet Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2015-2019
13.4.3.2 R&D Expenses, 2015-2019
13.4.3.3 Gross Profit, 2015-2019
13.4.3.4 Net Income, 2015-2019
13.4.3.5 EBDITA, 2015-2019
13.5 Atomwise, Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.5.4 Recent Developments, 2017-2020
13.6 Deep Genomics
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.6.4 Recent Developments, 2017-2020
13.7 Cloud Pharmaceuticals, Inc.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.8 Insilico Medicine
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.8.4 Recent Developments, 2017-2020
13.9 BenevolentAI
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.9.4 Recent Developments, 2017-2020
13.10 Exscientia
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.10.4 Recent Developments, 2017-2020
13.11 Biosymetrics
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Recent Developments, 2019-2020
13.12 Euretos
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.12.4 Recent Developments, 2017-2020
13.13 Insitro
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Product Benchmarking
13.13.4 Recent Developments, 2019-2020
13.14 Cyclica
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Product Benchmarking
13.14.4 Recent Developments, 2017-2020
13.15 Biovista
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Product Benchmarking
13.15.4 Recent Developments, 2017-2020
13.16 OWKIN, INC.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Product Benchmarking
13.16.4 Recent Developments, 2018-2020
14 Conclusion



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 製薬における人工知能(AI)の世界市場2021年-2031年(Artificial Intelligence (AI) in Pharmaceutical Market Report 2021-2031)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆